Gilead increases limits on its assistance programs for PrEP

On July 23, 2018, Gilead (the manufacturer of Truvada) announced two major changes to their PrEP assistance programs. These changes will help address ongoing affordability challenges that many people are facing with today’s rising costs of health insurance.

First, the eligibility limit for the Copay Coupon Card program will increase from $4,800 annually to $7,200. (This applies to using Truvada for prevention as well as treatment.) All other enrollment terms remain the same. This change takes effect September 1, 2018.

Second, the Medication Assistance Program will extend its coverage time from 6 to 12 months, so eligible individuals won’t have to re-enroll as frequently. Again, other enrollment terms remain the same. This change takes effect July 1, 2018.

This information will be updated in PleasePrEPMe’s PrEP Navigation Manual to reflect these changes. If you have any questions about this development, please contact Alan McCord at amccord [at] projectinform [dot] org.